We've found
15,419
archived clinical trials in
Pulmonary
We've found
15,419
archived clinical trials in
Pulmonary
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Updated: 12/31/1969
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated: 12/31/1969
COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV
Updated: 12/31/1969
Implantation of the SAPIEN Transcatheter Heart Valve (THV) in the Pulmonic Position
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Intrapleural Catheter Daily Versus Three Times a Week Drainage
Updated: 12/31/1969
Effectiveness of Daily Versus Three Times a Week Drainage After Placement of Intrapleural Catheters for the Palliative Management of Pleural Effusions Associated With Malignancies
Status: Enrolling
Updated: 12/31/1969
Intrapleural Catheter Daily Versus Three Times a Week Drainage
Updated: 12/31/1969
Effectiveness of Daily Versus Three Times a Week Drainage After Placement of Intrapleural Catheters for the Palliative Management of Pleural Effusions Associated With Malignancies
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients
Updated: 12/31/1969
Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients
Status: Enrolling
Updated: 12/31/1969
Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients
Updated: 12/31/1969
Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea
Updated: 12/31/1969
Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea
Status: Enrolling
Updated: 12/31/1969
Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea
Updated: 12/31/1969
Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Updated: 12/31/1969
A Randomized, Double-Masked, Sponsor-Unmasked, Ascending Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRM-151 Administered Intravenously to Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Updated: 12/31/1969
A Randomized, Double-Masked, Sponsor-Unmasked, Ascending Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRM-151 Administered Intravenously to Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Updated: 12/31/1969
A Randomized, Double-Masked, Sponsor-Unmasked, Ascending Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRM-151 Administered Intravenously to Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Updated: 12/31/1969
A Randomized, Double-Masked, Sponsor-Unmasked, Ascending Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRM-151 Administered Intravenously to Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Updated: 12/31/1969
A Randomized, Double-Masked, Sponsor-Unmasked, Ascending Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRM-151 Administered Intravenously to Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Updated: 12/31/1969
A Randomized, Double-Masked, Sponsor-Unmasked, Ascending Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRM-151 Administered Intravenously to Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure
Updated: 12/31/1969
A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Dexmedetomidine and Propofol in Children With History of Obstructive Sleep Apnea
Updated: 12/31/1969
Effect of Increasing Depth of Dexmedetomidine and Propofol Anesthesia on Upper Airway Morphology in Children With History of Obstructive Sleep Apnea
Status: Enrolling
Updated: 12/31/1969
Dexmedetomidine and Propofol in Children With History of Obstructive Sleep Apnea
Updated: 12/31/1969
Effect of Increasing Depth of Dexmedetomidine and Propofol Anesthesia on Upper Airway Morphology in Children With History of Obstructive Sleep Apnea
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ranolazine in Ischemic Cardiomyopathy
Updated: 12/31/1969
Ranolazine in Ischemic Cardiomyopathy Patients With Persistent Chest Pain or Dyspnea Despite Conventional Therapy: A Cross-Over Study
Status: Enrolling
Updated: 12/31/1969
Ranolazine in Ischemic Cardiomyopathy
Updated: 12/31/1969
Ranolazine in Ischemic Cardiomyopathy Patients With Persistent Chest Pain or Dyspnea Despite Conventional Therapy: A Cross-Over Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Sweat Testing Using a Quantitative Patch
Updated: 12/31/1969
A Study of Sweat Testing Using a Quantitative Patch
Status: Enrolling
Updated: 12/31/1969
A Study of Sweat Testing Using a Quantitative Patch
Updated: 12/31/1969
A Study of Sweat Testing Using a Quantitative Patch
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Sweat Testing Using a Quantitative Patch
Updated: 12/31/1969
A Study of Sweat Testing Using a Quantitative Patch
Status: Enrolling
Updated: 12/31/1969
A Study of Sweat Testing Using a Quantitative Patch
Updated: 12/31/1969
A Study of Sweat Testing Using a Quantitative Patch
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study of Sweat Testing Using a Quantitative Patch
Updated: 12/31/1969
A Study of Sweat Testing Using a Quantitative Patch
Status: Enrolling
Updated: 12/31/1969
A Study of Sweat Testing Using a Quantitative Patch
Updated: 12/31/1969
A Study of Sweat Testing Using a Quantitative Patch
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis
Updated: 12/31/1969
Randomized Cross Over Study of Inhaled Hypertonic Xylitol Versus Hypertonic Saline in Stable Subjects With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis
Updated: 12/31/1969
Randomized Cross Over Study of Inhaled Hypertonic Xylitol Versus Hypertonic Saline in Stable Subjects With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis
Updated: 12/31/1969
Randomized Cross Over Study of Inhaled Hypertonic Xylitol Versus Hypertonic Saline in Stable Subjects With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis
Updated: 12/31/1969
Randomized Cross Over Study of Inhaled Hypertonic Xylitol Versus Hypertonic Saline in Stable Subjects With Cystic Fibrosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clearance Of Mucus In Stents (COMIS)
Updated: 12/31/1969
Clearance Of Mucus In Stents (COMIS)
Status: Enrolling
Updated: 12/31/1969
Clearance Of Mucus In Stents (COMIS)
Updated: 12/31/1969
Clearance Of Mucus In Stents (COMIS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Effect of Ketoconazole on Breathlessness
Updated: 12/31/1969
The Effect of Ketoconazole on Breathlessness During Resistive Load Breathing in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Effect of Ketoconazole on Breathlessness
Updated: 12/31/1969
The Effect of Ketoconazole on Breathlessness During Resistive Load Breathing in Patients With Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Prize Contingency Management for Cocaine-Dependent Methadone Patients
Updated: 12/31/1969
Prize Contingency Management for Cocaine-Dependent Methadone Patients
Status: Enrolling
Updated: 12/31/1969
Prize Contingency Management for Cocaine-Dependent Methadone Patients
Updated: 12/31/1969
Prize Contingency Management for Cocaine-Dependent Methadone Patients
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Updated: 12/31/1969
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
Updated: 12/31/1969
Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
Status: Enrolling
Updated: 12/31/1969
Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
Updated: 12/31/1969
Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Vitamin D for Sickle-cell Respiratory Complications
Updated: 12/31/1969
Vitamin D for Sickle-cell Respiratory Complications
Status: Enrolling
Updated: 12/31/1969
Vitamin D for Sickle-cell Respiratory Complications
Updated: 12/31/1969
Vitamin D for Sickle-cell Respiratory Complications
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)
Updated: 12/31/1969
Double-blind Placebo-controlled Pilot Study of Sirolimus in IPF
Status: Enrolling
Updated: 12/31/1969
Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)
Updated: 12/31/1969
Double-blind Placebo-controlled Pilot Study of Sirolimus in IPF
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
Updated: 12/31/1969
Pilot Randomized Clinical Trial of Inhaled PGE1 in Neonates With Sub-Optimal Response to Inhaled Nitric Oxide
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials